SAIZEN

This brand name is authorized in Australia, Austria, Brazil, Canada, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, New Zealand, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug SAIZEN contains one active pharmaceutical ingredient (API):

1
UNII NQX9KB6PCL - SOMATROPIN
 

Somatropin is a potent metabolic hormone of importance for the metabolism of lipids, carbohydrates and proteins. In children with inadequate endogenous growth hormone, somatropin stimulates linear growth and increases growth rate. In adults, as well as in children, somatropin maintains a normal body composition by increasing nitrogen retention and stimulation of skeletal muscle growth, and by mobilization of body fat.

 
Read more about Somatropin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
H01AC01 Somatropin H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01A Anterior pituitary lobe hormones and analogues → H01AC Somatropin and somatropin agonists
Discover more medicines within H01AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 10442N, 10458K, 10462P, 10483R, 10495J, 10497L, 3388H, 5822K, 5824M
BR Câmara de Regulação do Mercado de Medicamentos 525414030044703, 525414030044803, 525414030044903, 525420501158310, 525420502154319
CA Health Products and Food Branch 02237971, 02350122, 02350130, 02350149
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria H7731013, H7741013
EE Ravimiamet 1043705, 1064269, 1415528, 1415539, 1415540, 1415551, 1415562, 1415573
ES Centro de información online de medicamentos de la AEMPS 73842, 73843
FI Lääkealan turvallisuus- ja kehittämiskeskus 072089, 072111, 072122, 072133
FR Base de données publique des médicaments 65196244, 66623496
GB Medicines & Healthcare Products Regulatory Agency 186682, 186690, 186696, 46536
HK Department of Health Drug Office 48913, 61542, 61543, 61544
IE Health Products Regulatory Authority 88202, 88259, 88311
NZ Medicines and Medical Devices Safety Authority 15527, 15528
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W66036001, W66036002, W66037001, W66037002, W66037003, W66037004
SG Health Sciences Authority 07437P, 14425P, 14432P, 14433P
TN Direction de la Pharmacie et du Médicament 14663011H, 14663012H, 14663013H, 4043021H
TR İlaç ve Tıbbi Cihaz Kurumu 8699777794018, 8699808794048, 8699808794055, 8699808794062, 8699808794079, 8699808794086, 8699808794093
ZA Health Products Regulatory Authority 28/21.10/0481, Y/21.10/244

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.